Tenet Healthcare price target raised to $100 from $90 at Mizuho

Mizuho analyst Ann Hynes raised the firm’s price target on Tenet Healthcare to $100 from $90 and keeps a Buy rating on the shares post the Q4 report. The company’s operating trends were impressive with both the acute and ambulatory surgery center segments, boasting double-digit adjusted EBITDA growth, the analyst tells investors in a research note.